Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative calcitriol dose to prevent postoperative hypocalcemia after parathyroidectomy in end-stage kidney disease
TCTR20240315002Phase 3Completed
- Sponsor
- Phramongkutklao Hospital and College of Medicine
- Start
- Mar 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of calcitriol in end-stage kidney disease (ESKD), secondary hyperparathyroidism (SHPT), sponsored by Phramongkutklao Hospital and College of Medicine. Started Mar 2023; status: completed.
02
Drugs
calcitriol
03
Conditions
end-stage kidney disease (ESKD)secondary hyperparathyroidism (SHPT)
Beyond the preview
Go deeper on TCTR20240315002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240315002.